• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LYU Xue,HU Lihong.An overview in research and development process of a novel γ-secretase modulator SPI-1865[J].Journal Of Pharmaceutical Research,2017,36(4):187-194[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3790times   Download 3142次 QR Code for this article
Scan with your phone!
新型γ-分泌酶调节剂SPI-1865的研发历程概述
吕薛,胡立宏
Font:Larger+|Default|Smaller-
(中国科学院大学,上海药物研究所,新药研究国家重点实验室,上海 201203)
摘要:
阿尔茨海默症(Alzheimer’s disease,AD)为进行性的神经退行性疾病,目前缺乏有效的治疗手段。β淀粉样蛋白(β-amyloid,Aβ)在脑神经细胞外过度沉积形成的寡聚体和淀粉样斑块与AD的发生、发展密切相关。γ-分泌酶是Aβ代谢过程中的关键酶,为研发AD治疗药物的关键靶点。针对此靶点研发的γ-分泌酶调节剂(γ-Secretase Modulators,GSM)因对Notch等蛋白影响较小,有广阔的应用前景。本文总结了源于黑升麻(Black cohosh,Cimicifuga racemosa)的环阿尔廷型三萜为先导物的结构优化历程,最终获得GSM药物候选物SPI-1865,以期为GSM的开发与改造提供有价值的参考。
关键词:  阿尔茨海默症  β淀粉样蛋白  γ-分泌酶  γ-分泌酶调节剂  SPI-1865
DOI:10.13506/j.cnki.jpr.2017.04.001
基金项目:国家自然科学基金项目(No.81561148011、No.81473110、No.81273397)
An overview in research and development process of a novel γ-secretase modulator SPI-1865
LYU Xue,HU Lihong
(State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,University of Chinese Academy of Sciences,Shanghai 201203,China)
Abstract:
Alzheimer’s disease is a progressive neurodegenerative disorder,which is lack of efficient treatment measures.The β-amyloid (Aβ) oligomers and senile plaques,which are the result of β-amyloid aggregation outside the brain neurons,are strongly implicated the pathogenesis of AD.γ-Secretase,a key enzyme involved in generation of Aβ,is a potential target in the development of drugs for AD therapy.γ-Secretase modulators are highly selective and have broad application prospects.This article briefly reviewed the development process of a novel γ-Secretase modulator SPI-1865,aiming at providing valuable information for development and structural modifications of related GSM.
Key words:  Alzheimer’s disease  β-amyloid  γ-Secretase  γ-Secretase modulators  SPI-1865
Today's Visits:488    Total Visits:2383203
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.